These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25120007)

  • 21. Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells.
    Favia M; Mancini MT; Bezzerri V; Guerra L; Laselva O; Abbattiscianni AC; Debellis L; Reshkin SJ; Gambari R; Cabrini G; Casavola V
    Am J Physiol Lung Cell Mol Physiol; 2014 Jul; 307(1):L48-61. PubMed ID: 24816489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.
    Luciani A; Villella VR; Esposito S; Brunetti-Pierri N; Medina D; Settembre C; Gavina M; Pulze L; Giardino I; Pettoello-Mantovani M; D'Apolito M; Guido S; Masliah E; Spencer B; Quaratino S; Raia V; Ballabio A; Maiuri L
    Nat Cell Biol; 2010 Sep; 12(9):863-75. PubMed ID: 20711182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Comparative Modeling of Multi-Domain F508del CFTR.
    McDonald EF; Woods H; Smith ST; Kim M; Schoeder CT; Plate L; Meiler J
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
    Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
    PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
    Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
    Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correctors of mutant CFTR enhance subcortical cAMP-PKA signaling through modulating ezrin phosphorylation and cytoskeleton organization.
    Abbattiscianni AC; Favia M; Mancini MT; Cardone RA; Guerra L; Monterisi S; Castellani S; Laselva O; Di Sole F; Conese M; Zaccolo M; Casavola V
    J Cell Sci; 2016 Mar; 129(6):1128-40. PubMed ID: 26823603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809.
    Van Goor F; Hadida S; Grootenhuis PD; Burton B; Stack JH; Straley KS; Decker CJ; Miller M; McCartney J; Olson ER; Wine JJ; Frizzell RA; Ashlock M; Negulescu PA
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18843-8. PubMed ID: 21976485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770.
    Gentzsch M; Ren HY; Houck SA; Quinney NL; Cholon DM; Sopha P; Chaudhry IG; Das J; Dokholyan NV; Randell SH; Cyr DM
    Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L550-9. PubMed ID: 27402691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.
    Estabrooks S; Brodsky JL
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue of F508del-CFTR by RXR motif inactivation triggers proteome modulation associated with the unfolded protein response.
    Gomes-Alves P; Couto F; Pesquita C; Coelho AV; Penque D
    Biochim Biophys Acta; 2010 Apr; 1804(4):856-65. PubMed ID: 20044041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A chemical corrector modifies the channel function of F508del-CFTR.
    Kim Chiaw P; Wellhauser L; Huan LJ; Ramjeesingh M; Bear CE
    Mol Pharmacol; 2010 Sep; 78(3):411-8. PubMed ID: 20501743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant.
    Borgo C; D'Amore C; Capurro V; Tomati V; Pedemonte N; Bosello Travain V; Salvi M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation.
    Gong X; Ahner A; Roldan A; Lukacs GL; Thibodeau PH; Frizzell RA
    J Biol Chem; 2016 Jan; 291(4):2004-2017. PubMed ID: 26627832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.
    Pasyk S; Molinski S; Ahmadi S; Ramjeesingh M; Huan LJ; Chin S; Du K; Yeger H; Taylor P; Moran MF; Bear CE
    Proteomics; 2015 Jan; 15(2-3):447-61. PubMed ID: 25330774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A; Gong X; Frizzell RA
    FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia.
    Tomati V; Caci E; Ferrera L; Pesce E; Sondo E; Cholon DM; Quinney NL; Boyles SE; Armirotti A; Ravazzolo R; Galietta LJ; Gentzsch M; Pedemonte N
    JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?
    Heard A; Thompson J; Carver J; Bakey M; Wang XR
    Curr Drug Targets; 2015; 16(9):958-64. PubMed ID: 25981601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability.
    Meng X; Clews J; Kargas V; Wang X; Ford RC
    Cell Mol Life Sci; 2017 Jan; 74(1):23-38. PubMed ID: 27734094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.